Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Costanzo

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Pharmacoeconomics - Open|April 7, 2018
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational StudyClaudio Jommi, Patrizio Armeni, Margherita Battista, et al.
Blood Purification|June 1, 2011
Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortalityDiego Brancaccio, Mario Cozzolino, Giuseppe Cannella, et al.
Blood Purification|October 4, 2014
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: results of the FARO-2 cohortMario Cozzolino, Piergiorgio Messa, Diego Brancaccio, et al.
Journal of Medical Economics|June 19, 2012
Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO studyDaniela Paola Roggeri, Sandro Mazzaferro, Diego Brancaccio, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2012
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO SurveyMario Cozzolino, Diego Brancaccio, Giuseppe Cannella, et al.
The American Journal of Cardiology|March 8, 2013
Stress-induced hyperviscosity in the pathophysiology of takotsubo cardiomyopathyEmanuele Cecchi, Guido Parodi, Cristina Giglioli, et al.
Plos One|August 24, 2018
Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary careSilvio Borrelli, Paolo Chiodini, Luca De Nicola, et al.
Cell Stem Cell|June 21, 2023
A stem cell zoo uncovers intracellular scaling of developmental tempo across mammalsJorge Lázaro, Maria Costanzo, Marina Sanaki-Matsumiya, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2016
Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational studyLeonardo Lopiano, Nicola Modugno, Pietro Marano, et al.
Nephron|July 18, 2018
Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE StudyMario Cozzolino, Piergiorgio Bolasco, Claudio Ronco, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics - Open|April 7, 2018
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational StudyClaudio Jommi, Patrizio Armeni, Margherita Battista, et al.
Blood Purification|June 1, 2011
Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortalityDiego Brancaccio, Mario Cozzolino, Giuseppe Cannella, et al.
Blood Purification|October 4, 2014
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: results of the FARO-2 cohortMario Cozzolino, Piergiorgio Messa, Diego Brancaccio, et al.
Journal of Medical Economics|June 19, 2012
Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO studyDaniela Paola Roggeri, Sandro Mazzaferro, Diego Brancaccio, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2012
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO SurveyMario Cozzolino, Diego Brancaccio, Giuseppe Cannella, et al.
The American Journal of Cardiology|March 8, 2013
Stress-induced hyperviscosity in the pathophysiology of takotsubo cardiomyopathyEmanuele Cecchi, Guido Parodi, Cristina Giglioli, et al.
Plos One|August 24, 2018
Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary careSilvio Borrelli, Paolo Chiodini, Luca De Nicola, et al.
Cell Stem Cell|June 21, 2023
A stem cell zoo uncovers intracellular scaling of developmental tempo across mammalsJorge Lázaro, Maria Costanzo, Marina Sanaki-Matsumiya, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2016
Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational studyLeonardo Lopiano, Nicola Modugno, Pietro Marano, et al.
Nephron|July 18, 2018
Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE StudyMario Cozzolino, Piergiorgio Bolasco, Claudio Ronco, et al.
Pageof 4